CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,712,859
- in 10 filings, $1.0M under 10b5-1 plans
Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-05 | COLUMN GROUP L P 10% owner | Other disposition | −1,000,000 | 989,000 | ||
| 2021-05-05 | COLUMN GROUP L P 10% owner | Other acquisition | +49,689 | 49,689 | ||
| 2021-05-05 | COLUMN GROUP L P 10% owner | Other disposition | −49,689 | 0 | ||
| 2021-05-05 | COLUMN GROUP L P 10% owner | Other acquisition | +17,829 | 134,010 | ||
| 2021-05-05 | COLUMN GROUP L P 10% owner | Other acquisition | +17,829 | 139,383 | ||
| 2021-05-05 | COLUMN GROUP L P 10% owner | Other acquisition | +7,752 | 48,406 | ||
| 2021-05-03 | Hansen Gwenn Chief Scientific Officer | Exercise or conversion | +800 | $7.26 | $6K | 14,604 |
| 2021-05-03 | Hansen Gwenn Chief Scientific Officer | Sale | −800 | $35.00 | $28K | 13,804 |
| 2021-05-03 | Hansen Gwenn Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −800 | 72,666 | ||
| 2021-04-28 | Ring Christine General Counsel | Exercise or conversion | +800 | $1.86 | $1K | 1,605 |
| 2021-04-28 | Ring Christine General Counsel | Sale | −800 | $35.25 | $28K | 805 |
| 2021-04-28 | Ring Christine General Counsel | Exercise or conversion · Employee Stock Option (right to buy) | −800 | 115,666 | ||
| 2021-04-12 | Ring Christine General Counsel | Exercise or conversion | +1,200 | $1.86 | $2K | 2,005 |
| 2021-04-12 | Ring Christine General Counsel | Sale | −1,200 | $27.20 | $33K | 805 |
| 2021-04-12 | Ring Christine General Counsel | Exercise or conversion · Employee Stock Option (right to buy) | −1,200 | 116,466 | ||
| 2021-04-12 | Beaurang Pierre Chief Business Officer | Exercise or conversion | +2,396 | $0.84 | $2K | 6,726 |
| 2021-04-12 | Beaurang Pierre Chief Business Officer | Exercise or conversion | +5,104 | $1.11 | $6K | 11,830 |
| 2021-04-12 | Beaurang Pierre Chief Business Officer | Sale | −4,072 | $26.83 | $109K | 7,758 |
| 2021-04-12 | Beaurang Pierre Chief Business Officer | Sale | −2,883 | $27.67 | $80K | 4,875 |
| 2021-04-12 | Beaurang Pierre Chief Business Officer | Sale | −545 | $28.65 | $16K | 4,330 |
Page 36 of 42 · 829 trades